![[Updated] Healthtech firm Biofourmis to earn unicorn status with General Atlantic funding](https://media.dealstreetasia.com/uploads/2022/04/doctor.jpg?fit=978,555&resize=1920,undefined&q=75)
Digital therapeutics firm Biofourmis, which was founded in Singapore, is set to bag new funding from growth equity firm General Atlantic in a deal that will value it at over $1 billion, according to two sources familiar with the matter.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
